CPT — Copyright/Patent/Trademark
S.1040, to prohibit product hopping and for other purposes; proposals regarding patent thickets
Lobbyists:
Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE
1st Quarter - Report · 2026
- Filing UUID
c3f1dd78-8f2c-4a14-b826-150a8b5cac40- Type
Q1— 1st Quarter - Report- Period
- first_quarter
- Year
- 2026
- Posted
- 2026-04-20 16:55:25
- Income (reported)
- —
- Expenses (reported)
- $200,000
- Expenses method
- A
- Filing document
- Open on lda.senate.gov
Registrant (lobbying firm)
Pharmaceuticals
- Contact
- CHRISTOPHER PORTER
- Phone
- +1 877-969-7879
- Address
- zip:92130, city:San Diego, state:CA, street:3611 Valley Centre Drive Suite 300
Client
Biopharmaceuticals
- State
- CA
- Country
- US
- Government-entity client
- false
- Effective date
- 2016-08-15
Issues lobbied + lobbyists (6)
HCR — Health Issues
Legislation regarding the Orphan Drug Act and rare disease diagnosis, treatment, and care. Legislation regarding kidney disease and in particular rare kidney disease. HR 1518, the New Era of Preventing End-Stage Kidney Disease Act; end-stage renal disease policy and rare kidney disease
Lobbyists:
Government entities lobbied: Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE
PHA — Pharmacy
HR 946 and S. 1862, Optimizing Research Progress Hope and New Cures (ORPHAN Cures Act); related provisions in H.R.1, One Big Beautiful Bill Act; Most Favored Nation and international reference pricing proposals
Lobbyists:
Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE
MED — Medical/Disease Research/Clinical Labs
HR 1262, S 932 Give Kids a Chance Act to renew PRV program; related provisions in H.R.1, One Big Beautiful Bill Act; HR 4709, the Newborn Screening Reauthorization Act; PDUFA/regulatory review process
Lobbyists:
Government entities lobbied: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE
MMM — Medicare/Medicaid
Regulations regarding transparency, reimbursement and care, particularly regarding rare disease. Medicare and Medicaid related provisions in H.R.1, One Big Beautiful Bill Act.
Lobbyists:
Government entities lobbied: Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; SENATE
TAX — Taxation/Internal Revenue Code
H.R. 1414, Cameron's Law to increase Orphan Drug Tax Credit to 50%; R&D tax credit; related implementation provisions in H.R.1, One Big Beautiful Bill Act; tariffs
Lobbyists:
Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE